Literature DB >> 9055800

Programming of a movement sequence in Parkinson's disease.

P Weiss1, G E Stelmach, H Hefter.   

Abstract

The execution of multiple-component movements has been shown to be impaired in Parkinson's disease patients. To determine whether this deficit is attributed to faulty motor programming, a two-segment movement was examined by studying the kinematics of the first segment when the second segment contained variable accuracy requirements. The performance of 15 Parkinson's disease patients was compared with an age-matched control group. Movement precision not only affected the kinematics of the final segment but also the kinematics of the first segment. This 'context effect' was observed in both groups. Since Parkinson's disease patients revealed similar movement patterns to those of controls, their motor programming appears to be intact. Furthermore, correlation analysis for the segment movement-times revealed subjects with high as well as low correlation indices in both groups. The correlation indices were related to the context effect only in the Parkinson's disease patients. Independent of these phenomenon. Parkinson's disease patients showed marked hesitations between the movement segments compared with controls, suggesting that they have difficulty in implementing and/or in switching between motor program steps. Impaired force control and a reduced capacity to terminate movements in Parkinson's disease are discussed as possible explanations of the deficit in motor program implementation.

Entities:  

Mesh:

Year:  1997        PMID: 9055800     DOI: 10.1093/brain/120.1.91

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Voice and fluency changes as a function of speech task and deep brain stimulation.

Authors:  Diana Van Lancker Sidtis; Tiffany Rogers; Violette Godier; Michele Tagliati; John J Sidtis
Journal:  J Speech Lang Hear Res       Date:  2010-07-19       Impact factor: 2.297

2.  Submovements during pointing movements in Parkinson's disease.

Authors:  Natalia Dounskaia; Laetitia Fradet; Gyusung Lee; Berta C Leis; Charles H Adler
Journal:  Exp Brain Res       Date:  2008-12-02       Impact factor: 1.972

3.  Effects of auditory feedback on movements with two-segment sequence and eye-hand coordination.

Authors:  Miya K Rand
Journal:  Exp Brain Res       Date:  2018-08-28       Impact factor: 1.972

4.  Formulaic Language in Parkinson's Disease and Alzheimer's Disease: Complementary Effects of Subcortical and Cortical Dysfunction.

Authors:  Diana Van Lancker Sidtis; JiHee Choi; Amy Alken; John J Sidtis
Journal:  J Speech Lang Hear Res       Date:  2015-10       Impact factor: 2.297

5.  Segment interdependency and gaze anchoring during manual two-segment sequences.

Authors:  Miya K Rand
Journal:  Exp Brain Res       Date:  2014-04-26       Impact factor: 1.972

6.  Face-referenced measurement of perioral stiffness and speech kinematics in Parkinson's disease.

Authors:  Shin Ying Chu; Steven M Barlow; Jaehoon Lee
Journal:  J Speech Lang Hear Res       Date:  2015-04       Impact factor: 2.297

7.  Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease.

Authors:  Matthew B Spraker; Janey Prodoehl; Daniel M Corcos; Cynthia L Comella; David E Vaillancourt
Journal:  Hum Brain Mapp       Date:  2010-03-11       Impact factor: 5.038

8.  Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus.

Authors:  M Desmurget; R S Turner
Journal:  J Neurophysiol       Date:  2007-12-12       Impact factor: 2.714

9.  Integration deficiencies associated with continuous limb movement sequences in Parkinson's disease.

Authors:  Jin-Hoon Park; George E Stelmach
Journal:  Parkinsonism Relat Disord       Date:  2009-04-26       Impact factor: 4.891

10.  Sensorimotor control of vocal pitch and formant frequencies in Parkinson's disease.

Authors:  Fatemeh Mollaei; Douglas M Shiller; Shari R Baum; Vincent L Gracco
Journal:  Brain Res       Date:  2016-06-08       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.